Achieving asthma control in practice: understanding the reasons for poor control

John Haughney, David Brendan Price, Alan Kaplan, Henry Chrystyn, Rob Horne, Nick May, Mandy Moffat, Jennifer Versnel, Eamonn R Shanahan, Elizabeth V Hillyer, Alf Tunsäter, Leif Bjermer

Research output: Contribution to journalArticle

156 Citations (Scopus)

Abstract

Achieving asthma control remains an elusive goal for the majority of patients worldwide. Ensuring a correct diagnosis of asthma is the first step in assessing poor symptom control; this requires returning to the basics of history taking and physical examination, in conjunction with lung function measurement when appropriate. A number of factors may contribute to sub-optimal asthma control. Concomitant rhinitis, a common co-pathology and contributor to poor control, can often be identified by asking a simple question. Smoking too has been identified as a cause of poor asthma control. Practical barriers such as poor inhaler technique must be addressed. An appreciation of patients' views and concerns about maintenance asthma therapy can help guide discussion to address perceptual barriers to taking maintenance therapy (doubts about personal necessity and concerns about potential adverse effects). Further study into, and a greater consideration of, factors and patient characteristics that could predict individual responses to asthma therapies are needed. Finally, more clinical trials that enrol patient populations reflecting the real world diversity of patients seen in clinical practice, including wide age ranges, presence of comorbidities, current smoking, and differing ethnic origins, will contribute to better individual patient management.
Original languageEnglish
Pages (from-to)1681-1693
Number of pages13
JournalRespiratory Medicine
Volume102
Issue number12
Early online date23 Sep 2008
DOIs
Publication statusPublished - Dec 2008

Keywords

  • Adult
  • Anti-Asthmatic Agents
  • Asthma
  • Child
  • Drug Resistance
  • Glucocorticoids
  • Humans
  • Nebulizers and Vaporizers
  • Patient Compliance
  • Patient Education as Topic
  • Randomized Controlled Trials as Topic
  • Rhinitis
  • Smoking

Cite this

Achieving asthma control in practice : understanding the reasons for poor control. / Haughney, John; Price, David Brendan; Kaplan, Alan; Chrystyn, Henry; Horne, Rob; May, Nick; Moffat, Mandy; Versnel, Jennifer; Shanahan, Eamonn R; Hillyer, Elizabeth V; Tunsäter, Alf; Bjermer, Leif.

In: Respiratory Medicine, Vol. 102, No. 12, 12.2008, p. 1681-1693.

Research output: Contribution to journalArticle

Haughney, J, Price, DB, Kaplan, A, Chrystyn, H, Horne, R, May, N, Moffat, M, Versnel, J, Shanahan, ER, Hillyer, EV, Tunsäter, A & Bjermer, L 2008, 'Achieving asthma control in practice: understanding the reasons for poor control', Respiratory Medicine, vol. 102, no. 12, pp. 1681-1693. https://doi.org/10.1016/j.rmed.2008.08.003
Haughney, John ; Price, David Brendan ; Kaplan, Alan ; Chrystyn, Henry ; Horne, Rob ; May, Nick ; Moffat, Mandy ; Versnel, Jennifer ; Shanahan, Eamonn R ; Hillyer, Elizabeth V ; Tunsäter, Alf ; Bjermer, Leif. / Achieving asthma control in practice : understanding the reasons for poor control. In: Respiratory Medicine. 2008 ; Vol. 102, No. 12. pp. 1681-1693.
@article{a5e801a821a44849821bb9698d6746e8,
title = "Achieving asthma control in practice: understanding the reasons for poor control",
abstract = "Achieving asthma control remains an elusive goal for the majority of patients worldwide. Ensuring a correct diagnosis of asthma is the first step in assessing poor symptom control; this requires returning to the basics of history taking and physical examination, in conjunction with lung function measurement when appropriate. A number of factors may contribute to sub-optimal asthma control. Concomitant rhinitis, a common co-pathology and contributor to poor control, can often be identified by asking a simple question. Smoking too has been identified as a cause of poor asthma control. Practical barriers such as poor inhaler technique must be addressed. An appreciation of patients' views and concerns about maintenance asthma therapy can help guide discussion to address perceptual barriers to taking maintenance therapy (doubts about personal necessity and concerns about potential adverse effects). Further study into, and a greater consideration of, factors and patient characteristics that could predict individual responses to asthma therapies are needed. Finally, more clinical trials that enrol patient populations reflecting the real world diversity of patients seen in clinical practice, including wide age ranges, presence of comorbidities, current smoking, and differing ethnic origins, will contribute to better individual patient management.",
keywords = "Adult, Anti-Asthmatic Agents, Asthma, Child, Drug Resistance, Glucocorticoids, Humans, Nebulizers and Vaporizers, Patient Compliance, Patient Education as Topic, Randomized Controlled Trials as Topic, Rhinitis, Smoking",
author = "John Haughney and Price, {David Brendan} and Alan Kaplan and Henry Chrystyn and Rob Horne and Nick May and Mandy Moffat and Jennifer Versnel and Shanahan, {Eamonn R} and Hillyer, {Elizabeth V} and Alf Tuns{\"a}ter and Leif Bjermer",
year = "2008",
month = "12",
doi = "10.1016/j.rmed.2008.08.003",
language = "English",
volume = "102",
pages = "1681--1693",
journal = "Respiratory Medicine",
issn = "0954-6111",
publisher = "Elsevier",
number = "12",

}

TY - JOUR

T1 - Achieving asthma control in practice

T2 - understanding the reasons for poor control

AU - Haughney, John

AU - Price, David Brendan

AU - Kaplan, Alan

AU - Chrystyn, Henry

AU - Horne, Rob

AU - May, Nick

AU - Moffat, Mandy

AU - Versnel, Jennifer

AU - Shanahan, Eamonn R

AU - Hillyer, Elizabeth V

AU - Tunsäter, Alf

AU - Bjermer, Leif

PY - 2008/12

Y1 - 2008/12

N2 - Achieving asthma control remains an elusive goal for the majority of patients worldwide. Ensuring a correct diagnosis of asthma is the first step in assessing poor symptom control; this requires returning to the basics of history taking and physical examination, in conjunction with lung function measurement when appropriate. A number of factors may contribute to sub-optimal asthma control. Concomitant rhinitis, a common co-pathology and contributor to poor control, can often be identified by asking a simple question. Smoking too has been identified as a cause of poor asthma control. Practical barriers such as poor inhaler technique must be addressed. An appreciation of patients' views and concerns about maintenance asthma therapy can help guide discussion to address perceptual barriers to taking maintenance therapy (doubts about personal necessity and concerns about potential adverse effects). Further study into, and a greater consideration of, factors and patient characteristics that could predict individual responses to asthma therapies are needed. Finally, more clinical trials that enrol patient populations reflecting the real world diversity of patients seen in clinical practice, including wide age ranges, presence of comorbidities, current smoking, and differing ethnic origins, will contribute to better individual patient management.

AB - Achieving asthma control remains an elusive goal for the majority of patients worldwide. Ensuring a correct diagnosis of asthma is the first step in assessing poor symptom control; this requires returning to the basics of history taking and physical examination, in conjunction with lung function measurement when appropriate. A number of factors may contribute to sub-optimal asthma control. Concomitant rhinitis, a common co-pathology and contributor to poor control, can often be identified by asking a simple question. Smoking too has been identified as a cause of poor asthma control. Practical barriers such as poor inhaler technique must be addressed. An appreciation of patients' views and concerns about maintenance asthma therapy can help guide discussion to address perceptual barriers to taking maintenance therapy (doubts about personal necessity and concerns about potential adverse effects). Further study into, and a greater consideration of, factors and patient characteristics that could predict individual responses to asthma therapies are needed. Finally, more clinical trials that enrol patient populations reflecting the real world diversity of patients seen in clinical practice, including wide age ranges, presence of comorbidities, current smoking, and differing ethnic origins, will contribute to better individual patient management.

KW - Adult

KW - Anti-Asthmatic Agents

KW - Asthma

KW - Child

KW - Drug Resistance

KW - Glucocorticoids

KW - Humans

KW - Nebulizers and Vaporizers

KW - Patient Compliance

KW - Patient Education as Topic

KW - Randomized Controlled Trials as Topic

KW - Rhinitis

KW - Smoking

U2 - 10.1016/j.rmed.2008.08.003

DO - 10.1016/j.rmed.2008.08.003

M3 - Article

C2 - 18815019

VL - 102

SP - 1681

EP - 1693

JO - Respiratory Medicine

JF - Respiratory Medicine

SN - 0954-6111

IS - 12

ER -